CJC-1295: The Sustained Growth Hormone Driver
Protocol

CJC-1295: The Sustained Growth Hormone Driver

The partner to Ipamorelin. Learn the critical difference between "DAC" and "No DAC" and why one is safe and the other is dangerous.

ByPeptide Bioregulator Atlas
May 15, 2024
9 min read

Table of Contents

What is CJC-1295?

CJC-1295 is a synthetic analogue of Growth Hormone Releasing Hormone (GHRH). In simple terms, it mimics the body's natural signal to the pituitary gland to produce and secrete Growth Hormone (GH). Developed to treat medical conditions like lipodystrophy and growth hormone deficiency, it has become a staple in the performance and anti-aging communities for its ability to naturally amplify GH pulses without the shutdown associated with exogenous HGH administration. Unlike HGH injections, which replace your body's natural production, CJC-1295 enhances it. It works best when synergistic pathways are targeted (see Stacking below).

Mechanism of Action

CJC-1295 binds to the GHRH receptors in the anterior pituitary gland.

  • The Signal: It acts as a "key," unlocking the pituitary cells and priming them to release growth hormone.
  • The Pulse: It amplifies the natural rhythm of GH release.
  • The Result: Higher peaks of GH throughout the day and night, leading to increased IGF-1 (Insulin-like Growth Factor 1) levels in the liver. IGF-1 is the primary mediator of GH's anabolic effects.

The Critical Distinction: DAC vs. No DAC

This is the most misunderstood and crucial aspect of CJC-1295. There are two distinct forms, and knowing the difference is a matter of safety.

1. CJC-1295 with DAC (Drug Affinity Complex)

  • Structure: It has a "Drug Affinity Complex" added, which allows it to bind to albumin in the blood.
  • Half-Life: ~8 Days.
  • Effect: Because it lasts so long, it creates a constant, low-grade "bleed" of Growth Hormone.
  • The Danger: This constant elevation destroys the natural pulsatile release of GH. The pituitary gland is meant to pulse, not stream. "GH Bleed" leads to desensitization, potential pituitary damage, and significant insulin resistance.
  • Verdict: AVOID. Most experienced researchers consistently warn against the DAC version due to these side effect profiles.

2. CJC-1295 No DAC (Mod GRF 1-29)

  • Structure: This is often referred to as "Mod GRF 1-29" in older literature. It is the modified version of the first 29 amino acids of GHRH.
  • Half-Life: ~30 Minutes.
  • Effect: It mimics the natural spike of GHRH. It clears the system quickly.
  • Verdict: PREFERRED. This form allows for flexible dosing that can be timed to mimic the body's natural circadian rhythm (e.g., pre-bed or post-workout). It respects biological feedback loops.

(Note: In the rest of this guide, "CJC-1295" refers to the No DAC / Mod GRF 1-29 version unless specified).

Benefits of CJC-1295

By elevating plasma GH and IGF-1 levels, users typically observe:

  • Increased Lean Muscle Mass: Enhances protein synthesis and nitrogen retention.
  • Fat Loss: Accelerates lipolysis (fat breakdown), particularly visceral fat.
  • Improved Recovery: Faster soft tissue repair (tendons/ligaments) and reduced recovery time between workouts.
  • Better Sleep: Many users report deeper, more restorative slow-wave sleep.
  • Anti-Aging: Improved skin elasticity and collagen production.

The Ipamorelin Synergy (The "No DAC" Stack)

CJC-1295 is rarely used alone. It is almost always stacked with a GHRP (Growth Hormone Releasing Peptide) like Ipamorelin.

  • Why? CJC-1295 increases the amount of GH released per pulse. Ipamorelin ensures the pulse happens.
  • The Analogy: CJC-1295 unlocks the door. Ipamorelin pushes it open.
  • Synergy: Taken together, the release of GH is not just additive (1+1=2) but synergistic (1+1=5). This combination is widely considered the "Gold Standard" for anti-aging and mild performance enhancement.

Side Effects

CJC-1295 is generally well-tolerated, but common side effects (especially immediately post-injection) include:

  • The "Head Rush": A feeling of warmth or flushing in the face and temples (vasodilation) about 5-10 minutes after injection. This is normal and usually subsides quickly.
  • Injection Site Reaction: Mild pain or redness.
  • Water Retention: Usually dose-dependent and less severe than with HGH.
  • Insulin Sensitivity: High doses can temporarily reduce insulin sensitivity; monitor blood glucose if predisposed.

Dosing Protocol (Research Purposes)

A standard protocol for CJC-1295 No DAC is often synchronized with Ipamorelin.

  • Recommended Dose: 100mcg of CJC-1295.
  • Frequency: 1-3 times daily.
  • Timing:
    • Morning: Upon waking (fasted).
    • Post-Workout: Immediately after training.
    • Pre-Bed: The most important dose to enhance the natural nocturnal GH spike.
  • Saturation Dose: Research suggests the pituitary receptors for GHRH saturate around 100mcg/kg (often simplified to 100mcg total for an average human). Doses higher than 100mcg offer diminishing returns.

Reconstitution and Storage

  • Reconstitution: Add Bacteriostatic Water slowly down the side of the vial. Do not shake; swirl gently.
  • Storage: Keep refrigerated (2-8°C). Once reconstituted, use within 3-4 weeks for maximum potency. Protect from direct light.
Share this article